This February Biotech and Money returns to London for its 3rd annual conference. From 7-8th February 400+ delegates, 100+ speakers and 150+ investors will come together for this two-day conference and partnering event, providing the education, strategies, solutions and contacts that life science companies need to enable more effective funding, investment, business planning and partnering within their businesses.
The quality of the agenda and calibre of the speakers is testament to the importance of this event, including keynote panels with leading UK, EU and US life science funds. Of particular interest in our current climate is the keynote panel ‘State of the Nation(s): UK, EU and US Capital Flow’, moderated by Fiona Barry of BioPharm Insight and Mergermarket Group.
In addition to the traditional, and highly successful, investment content on day one, Biotech and Money has introduced a Medtech and Money Day to help medtech executives, investors and pharma access high-value collaboration opportunities. Not only will this allow innovative UK and European medtech companies to hear from and meet prospective partners, but it will also maximise their chances of deal making. This expansion was the result of unprecedented demand from the Biotech and Money community, an indication of the previous success and relevance of this conference
The core mission of Biotech and Money London is to help build linkages and business opportunities for UK life science companies, capital and partners. Their focus is on quality peer-2-peer discussion, high-level networking and partnering, unique formats and a vetted, high calibre audience. This will be a truly international conference with pan-European and US attendees and speakers, and is not an event to miss. Register for your place here.
If you are a member of the press and would like to request a press pass for this event please contact Lea Bidiville, Marketing Executive, Biotech and Money.